List of Tables
Table 1. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Receptor Tyrosine Protein Kinase Targeted Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Receptor Tyrosine Protein Kinase Targeted Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Receptor Tyrosine Protein Kinase Targeted Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Receptor Tyrosine Protein Kinase Targeted Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2020-2025)
Table 51. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2026-2031)
Table 52. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2020-2025)
Table 61. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2026-2031)
Table 62. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Application (2026-2031)
Table 70. Aslan Pharmaceuticals Pte Ltd Company Information
Table 71. Aslan Pharmaceuticals Pte Ltd Description and Business Overview
Table 72. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 74. Aslan Pharmaceuticals Pte Ltd Recent Developments/Updates
Table 75. Boehringer Ingelheim GmbH Company Information
Table 76. Boehringer Ingelheim GmbH Description and Business Overview
Table 77. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 79. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 80. GamaMabs Pharma SA Company Information
Table 81. GamaMabs Pharma SA Description and Business Overview
Table 82. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 84. GamaMabs Pharma SA Recent Developments/Updates
Table 85. Hanmi Pharmaceuticals Co Ltd Company Information
Table 86. Hanmi Pharmaceuticals Co Ltd Description and Business Overview
Table 87. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 89. Hanmi Pharmaceuticals Co Ltd Recent Developments/Updates
Table 90. Jiangsu Kanion Pharmaceutical Co Ltd Company Information
Table 91. Jiangsu Kanion Pharmaceutical Co Ltd Description and Business Overview
Table 92. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 94. Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments/Updates
Table 95. Minerva Neurosciences Inc Company Information
Table 96. Minerva Neurosciences Inc Description and Business Overview
Table 97. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 99. Minerva Neurosciences Inc Recent Developments/Updates
Table 100. Pfizer Inc Company Information
Table 101. Pfizer Inc Description and Business Overview
Table 102. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 104. Pfizer Inc Recent Developments/Updates
Table 105. Puma Biotechnology Inc Company Information
Table 106. Puma Biotechnology Inc Description and Business Overview
Table 107. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 109. Puma Biotechnology Inc Recent Developments/Updates
Table 110. Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information
Table 111. Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Business Overview
Table 112. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 114. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments/Updates
Table 115. XuanZhu Pharma Co Ltd Company Information
Table 116. XuanZhu Pharma Co Ltd Description and Business Overview
Table 117. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 119. XuanZhu Pharma Co Ltd Recent Developments/Updates
Table 120. Zensun (Shanghai) Sci & Tech Co Ltd Company Information
Table 121. Zensun (Shanghai) Sci & Tech Co Ltd Description and Business Overview
Table 122. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product
Table 124. Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List
Table 128. Receptor Tyrosine Protein Kinase Targeted Drugs Customers List
Table 129. Receptor Tyrosine Protein Kinase Targeted Drugs Market Trends
Table 130. Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers
Table 131. Receptor Tyrosine Protein Kinase Targeted Drugs Market Challenges
Table 132. Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type: 2024 & 2031
Figure 4. Afatinib Dimaleate Product Picture
Figure 5. Dacomitinib Product Picture
Figure 6. Neratinib Product Picture
Figure 7. Neucardin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application: 2024 & 2031
Figure 11. Oncology
Figure 12. Cardiovascular
Figure 13. Central Nervous System
Figure 14. Others
Figure 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (2020-2031) & (US$ Million)
Figure 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (2020-2031) & (K Pcs)
Figure 18. Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 19. Receptor Tyrosine Protein Kinase Targeted Drugs Report Years Considered
Figure 20. Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Manufacturers in 2024
Figure 21. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Receptor Tyrosine Protein Kinase Targeted Drugs Players: Market Share by Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs in 2024
Figure 23. Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2020-2031)
Figure 26. North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2020-2031)
Figure 30. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2020-2031)
Figure 31. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2020-2031)
Figure 38. China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2020-2031)
Figure 49. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type (2020-2031)
Figure 59. Global Revenue Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type (2020-2031)
Figure 60. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Application (2020-2031)
Figure 62. Global Revenue Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Application (2020-2031)
Figure 63. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) by Application (2020-2031)
Figure 64. Receptor Tyrosine Protein Kinase Targeted Drugs Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
